These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19189698)

  • 21. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical activity and maximal oxygen uptake in adults with Prader-Willi syndrome.
    Gross I; Hirsch HJ; Constantini N; Nice S; Pollak Y; Genstil L; Eldar-Geva T; Tsur VG
    Eat Weight Disord; 2018 Oct; 23(5):615-620. PubMed ID: 28299717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early adiposity rebound in patients with Prader-Willi syndrome.
    Oto Y; Murakami N; Matsubara K; Ogata H; Ihara H; Matsubara T; Nagai T
    J Pediatr Endocrinol Metab; 2018 Dec; 31(12):1311-1314. PubMed ID: 30407912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
    L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
    Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.
    Mele C; Crinò A; Fintini D; Mai S; Convertino A; Bocchini S; Di Paolo P; Grugni G; Aimaretti G; Scacchi M; Marzullo P
    J Endocrinol Invest; 2021 Jul; 44(7):1447-1456. PubMed ID: 33067796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome.
    Davies PS; Joughin C
    Am J Ment Retard; 1993 Nov; 98(3):349-53. PubMed ID: 8292311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiposity indices in German children and adolescents with genetically confirmed Prader-Willi syndrome (PWS).
    Hauffa BP; Schlippe G; Gillessen-Kaesbach G
    Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S22-5. PubMed ID: 11466581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome.
    Marzullo P; Marcassa C; Campini R; Eleuteri E; Minocci A; Priano L; Temporelli P; Sartorio A; Vettor R; Liuzzi A; Grugni G
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5639-46. PubMed ID: 16030173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventilatory Responses During Submaximal Exercise in Children With Prader-Willi Syndrome.
    Hyde AM; McMurray RG; Chavoya FA; Rubin DA
    Pediatr Exerc Sci; 2018 Aug; 30(3):411-417. PubMed ID: 29485929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Body Composition, Muscle Strength and Cardiometabolic Profile in Children with Prader-Willi Syndrome and Non-Alcoholic Fatty Liver Disease: A Pilot Study.
    Mager DR; MacDonald K; Duke RL; Avedzi HM; Deehan EC; Yap J; Siminoski K; Haqq AM
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
    Whitman B; Carrel A; Bekx T; Weber C; Allen D; Myers S
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):591-600. PubMed ID: 15198290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of gait analysis in the rehabilitation of adult patients with "Prader-Willi" Syndrome: a cross-sectional comparative study ("Prader-Willi" Syndrome vs matched obese patients and healthy subjects).
    Vismara L; Romei M; Galli M; Montesano A; Baccalaro G; Crivellini M; Grugni G
    J Neuroeng Rehabil; 2007 May; 4():14. PubMed ID: 17493259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific Dietary Components and Gut Microbiota Composition are Associated with Obesity in Children and Adolescents with Prader-Willi Syndrome.
    Garcia-Ribera S; Amat-Bou M; Climent E; Llobet M; Chenoll E; Corripio R; Ibáñez L; Ramon-Krauel M; Lerin C
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32290434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of habitual physical activity in youth with and without Prader-Willi Syndrome.
    Castner DM; Tucker JM; Wilson KS; Rubin DA
    Res Dev Disabil; 2014 Nov; 35(11):3081-8. PubMed ID: 25129202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome.
    Grugni G; Crinò A; Pagani S; Meazza C; Buzi F; De Toni T; Gargantini L; Pilotta A; Pozzan GB; Radetti G; Ragusa L; Salvatoni A; Sartorio A; Bozzola M;
    J Pediatr Endocrinol Metab; 2011; 24(7-8):477-81. PubMed ID: 21932585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS).
    Fintini D; Inzaghi E; Colajacomo M; Bocchini S; Grugni G; Brufani C; Cappa M; Nobili V; Cianfarani S; Crinò A
    Pediatr Obes; 2016 Jun; 11(3):235-8. PubMed ID: 26132376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.